- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Polypore’s Celgard Unit Files Patent Suit Against Sumitomo Over Lithium Batteries
Bloomberg reported that Polypore International Inc.’s Celgard unit has filed a patent-infringement lawsuit against Sumitomo Chemical over a patent issued for a separator in high energy lithium ion batteries used in electric vehicles and electronics.
Bloomberg reported that Polypore International Inc.’s Celgard unit has filed a patent-infringement lawsuit against Sumitomo Chemical over a patent issued for a separator in high energy lithium ion batteries used in electric vehicles and electronics.
As quoted in the market news:
Sumitomo Chemical makes the chemicals and materials for lithium ion batteries that use Celgard’s invention without permission, according to the complaint. The separators are used in batteries made by Panasonic Corp. (6752) for laptop computers, Celgard said in the suit.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.